[PDF][PDF] A powerful approach to estimating annotation-stratified genetic covariance via GWAS summary statistics
Despite the success of large-scale genome-wide association studies (GWASs) on complex
traits, our understanding of their genetic architecture is far from complete. Jointly modeling …
traits, our understanding of their genetic architecture is far from complete. Jointly modeling …
[PDF][PDF] CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies
…, W Wells, A Gaur, RB Robey, JY Guo, RL Powles… - Cell reports, 2019 - cell.com
Although it is established that fatty acid (FA) synthesis supports anabolic growth in cancer,
the role of exogenous FA uptake remains elusive. Here we show that, during acquisition of …
the role of exogenous FA uptake remains elusive. Here we show that, during acquisition of …
[HTML][HTML] Leveraging functional annotations in genetic risk prediction for human complex diseases
Genetic risk prediction is an important goal in human genetics research and precision
medicine. Accurate prediction models will have great impacts on both disease prevention and …
medicine. Accurate prediction models will have great impacts on both disease prevention and …
[HTML][HTML] Integrative tissue-specific functional annotations in the human genome provide novel insights on many complex traits and improve signal prioritization in …
Extensive efforts have been made to understand genomic function through both experimental
and computational approaches, yet proper annotation still remains challenging, especially …
and computational approaches, yet proper annotation still remains challenging, especially …
[HTML][HTML] Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease
Continuing efforts from large international consortia have made genome-wide epigenomic
and transcriptomic annotation data publicly available for a variety of cell and tissue types. …
and transcriptomic annotation data publicly available for a variety of cell and tissue types. …
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity
…, H Qiu, Y Shan, D Banas, R Powles… - Science translational …, 2023 - science.org
Programmed cell death protein 1 (PD-1) immune checkpoint blockade therapy has
revolutionized cancer treatment. Although PD-1 blockade is effective in a subset of patients with …
revolutionized cancer treatment. Although PD-1 blockade is effective in a subset of patients with …
[HTML][HTML] Scalable and cost-effective NGS genotyping in the cloud
Background While next-generation sequencing (NGS) costs have plummeted in recent years,
cost and complexity of computation remain substantial barriers to the use of NGS in routine …
cost and complexity of computation remain substantial barriers to the use of NGS in routine …
Association of T-cell receptor repertoire use with response to combined trastuzumab-lapatinib treatment of HER2-positive breast cancer: secondary analysis of the …
Importance Dual anti-HER2 blockade increased the rate of pathologic complete response (pCR)
in the Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation (NeoALTTO) …
in the Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation (NeoALTTO) …
Analysis of pre-and posttreatment tissues from the SWOG S0800 trial reveals an effect of neoadjuvant chemotherapy on the breast cancer genome
RL Powles, VB Wali, X Li, WE Barlow, Z Nahleh… - Clinical Cancer …, 2020 - AACR
Purpose: We performed whole-exome sequencing (WES) of pre- and posttreatment cancer
tissues to assess the somatic mutation landscape of tumors before and after neoadjuvant …
tissues to assess the somatic mutation landscape of tumors before and after neoadjuvant …
[HTML][HTML] Genomic and immune profiling of a patient with triple-negative breast cancer that progressed during neoadjuvant chemotherapy plus PD-L1 blockade
D Casadevall, X Li, RL Powles, VB Wali… - JCO Precision …, 2019 - ncbi.nlm.nih.gov
Preliminary results from neoadjuvant trials combining immune checkpoint blockade (ICB)
with standardof-care chemotherapy suggest high pathologic complete response rates that …
with standardof-care chemotherapy suggest high pathologic complete response rates that …